Literature DB >> 32535095

Molecular mimicry may explain multi-organ damage in COVID-19.

Francesca Angileri1, Sébastien Legare2, Antonella Marino Gammazza3, Everly Conway de Macario4, Alberto Jl Macario5, Francesco Cappello6.   

Abstract

Entities:  

Keywords:  Anosmia; Kawasaki vasculitis; Leukopenia; Molecular mimicry; OR7D4; PARP9; SLC12A6; Severe acute respiratory syndrome coronavirus 2; Vascular damage

Mesh:

Substances:

Year:  2020        PMID: 32535095      PMCID: PMC7289093          DOI: 10.1016/j.autrev.2020.102591

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


× No keyword cloud information.
To the Editor, Molecular mimicry has been proposed as a cause of the autoimmune phenomena observed in COVID-19 [[1], [2], [3], [4]], the syndrome associated with the infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Lucchese and Flöel [4] have recently reported three human proteins (namely DAB1, AIFM, and SURF1, as catalogued at www.uniprot.org) – that are present in neurons of the respiratory pacemaker in the brainstem – that share potentially antigenic epitopes with SARS-CoV-2, as shown by in silico analysis. Particularly, they postulated that damage to the brainstem pacemaker may contribute to respiratory failure in COVID-19 as a consequence of molecular mimicry between neuronal and viral proteins, in turn causing the clinical dissociation between well-preserved lung mechanics and severity of hypoxemia. Here, we would like to direct attention to some features of COVID-19 – such as anosmia, leukopenia, and multi-organ failure brought about by vascular damage – that could also be the consequence of molecular mimicry phenomena (Table 1 ).
Table 1

Peptides of immunologic relevance shared between SARS-CoV-2 and human proteins.

Shared ≥6 mer (amino acids)SARS-CoV-2 proteinHuman proteinPutative Epitopes [NCBI Reference, SARS-CoV-2]Localization of human protein [predicted by uniprot.org]
IIFWFSLORF7bOR7D4 [Q8NG98]LVLIMLIIFWFSLELQ [YP_009725318.1]Cellular: olfactory receptor.Subcellular: plasma membrane.
VVNAANORF1abPARP9 [Q8IXQ6]VVNAANVYLKHGGGVAG [YP_009724389.1]Cellular: B cells; macrophage. Subcellular: cytosol, nucleus.
SSRSSSRNucleocapsid phosphor-proteinSLC12A6 [Q8NG98]SSRSSSRSRNSSRNSTP [YP_009724397]Cellular: endothelial cells; heart; brain; kidney; liver; lung. Subcellular: plasma membrane.
Peptides of immunologic relevance shared between SARS-CoV-2 and human proteins.

Observations

Odorant Receptor 7D4 (OR7D4) is one of the most important odorant receptors on the plasma membrane of olfactory sensory neurons, responding to sex steroid-derived odours, e.g., androstenone and androstadienone [5]. Its alterations have been associated with anxiety and depression [6]. Poly (ADP-Ribose) Polymerase Family Member 9 (PARP9), also known as mono-ADP-ribosyltransferase (ARTD)-9, is a protein involved in differentiation and function of immune cells such as B lymphocytes [7] and macrophages [8]. Solute Carrier Family 12 Member 6 (SLC12A6) is a member of the K—Cl cotransporters (KCC), integral membrane proteins that lower intracellular chloride concentrations [9]. Alternative splicing in its gene results in multiple transcript variants encoding different isoforms, the most important one being KCC3 [10]. The latter has been found in endothelial cells of various organs, including vessels, heart, brain, kidney, liver, and lung [11].

Working hypothesis

We hypothesize that anosmia, leukopenia, and vascular damage with multi-organ damage are associated with molecular mimicry of the following proteins: OR7D4: Anosmia. It could also be implicated in the mood disorders observed in these patients. PARP9: Leukopenia. It could be implicated in plaque destabilization in patients with atherosclerosis. SLC12A6: Vascular damage, in turn inducing thrombosis, disseminated intravascular coagulation, and multiorgan failure. It could also induce Kawasaki vasculitis. Interestingly, the shared epitope SSRSSSR in SLC12A6 (Table 1) was found to be highly immunogenic by SVMTriP (http://sysbio.unl.edu/SVMTriP/), a tool used to predict protein surface regions that are preferentially recognized by antibodies (i.e., antigenic epitopes), that is helping in the design of vaccine components [12]. Although plasma membrane localization has been demonstrated only for OR7D4 and SLC12A6, we cannot exclude that, after cell stress, post-translational modifications could induce PARP9 trafficking to plasma membrane and its exposure on the cell surface, as for other intracellular proteins [13]. Other studies, including the analysis of anatomical specimens from autopsies of subjects who died from severe forms of COVID-19, are necessary to verify these predictions.
  32 in total

1.  Overview of the Haematological Effects of COVID-19 Infection.

Authors:  T M Wiggill; E S Mayne; J L Vaughan; S Louw
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: An in silico approach.

Authors:  Gustavo Obando-Pereda
Journal:  J Med Virol       Date:  2021-06-11       Impact factor: 20.693

3.  SARS-CoV-2 infection as a trigger of autoimmune response.

Authors:  Maria C Sacchi; Stefania Tamiazzo; Paolo Stobbione; Lisa Agatea; Piera De Gaspari; Anna Stecca; Ernesto C Lauritano; Annalisa Roveta; Renato Tozzoli; Roberto Guaschino; Ramona Bonometti
Journal:  Clin Transl Sci       Date:  2021-01-21       Impact factor: 4.689

Review 4.  Concurrent myopathy and inflammatory cardiac disease in COVID-19 patients: a case series and literature review.

Authors:  Ophir Freund; Tali Eviatar; Gil Bornstein
Journal:  Rheumatol Int       Date:  2022-03-11       Impact factor: 3.580

5.  SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism.

Authors:  Guglielmo Lucchese; Agnes Flöel
Journal:  Cell Stress Chaperones       Date:  2020-07-29       Impact factor: 3.667

6.  Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19?

Authors:  Francesca Angileri; Sébastien Légaré; Antonella Marino Gammazza; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello
Journal:  Br J Haematol       Date:  2020-06-08       Impact factor: 6.998

7.  Positive Direct Antiglobulin Test in COVID-19 patients: decision-making process.

Authors:  Julien Cabo; Alice Brochier; Pascale Saussoy; Marie-Astrid van Dievoet; Lena Capirchio; Bénédicte Delire; Véronique Deneys
Journal:  Transfus Clin Biol       Date:  2021-06-07       Impact factor: 1.406

Review 8.  Emerging Infection, Vaccination, and Guillain-Barré Syndrome: A Review.

Authors:  Haruki Koike; Atsuro Chiba; Masahisa Katsuno
Journal:  Neurol Ther       Date:  2021-06-12

9.  Peptides of H. sapiens and P. falciparum that are predicted to bind strongly to HLA-A*24:02 and homologous to a SARS-CoV-2 peptide.

Authors:  Yekbun Adiguzel
Journal:  Acta Trop       Date:  2021-06-16       Impact factor: 3.112

10.  COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis.

Authors:  Cristoforo Pomara; Francesco Sessa; Marcello Ciaccio; Francesco Dieli; Massimiliano Esposito; Giovanni Maurizio Giammanco; Sebastiano Fabio Garozzo; Antonino Giarratano; Daniele Prati; Francesca Rappa; Monica Salerno; Claudio Tripodo; Pier Mannuccio Mannucci; Paolo Zamboni
Journal:  Diagnostics (Basel)       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.